This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Ken Yamada, Ph.D.
Assistant Professor at University of Massachusetts Medical School


Dr. Ken Yamada earned his BS, MS, and PhD (2011) at Tokyo Institute of Technology, Japan. His academic life with nucleic acid chemistry started when he was a PhD student in Prof. Mitsuo Sekine’s lab, where he cultivated his discipline as a nucleic acid chemist. After his career path led to a postdoctoral position in Prof. Masad Damha’s lab at McGill University (2012-2014) and an assistant professor position in Prof. Fumi Nagatsugi’s lab at Tohoku University (2014-2017), he joined Prof. Anastasia Khvorova’s lab to explore his potential as a chemist to contribute to the oligonucleotide therapeutics field. In the dynamic research culture of the Khvorova Lab, Ken has been pursuing transformative therapeutic RNA backbone chemistry that broadly impacts the oligonucleotide-based therapeutics research field. He currently holds Assistant Professor position in RNA Therapeutics Institute at UMass Medical School (2021-current) and is investigating new chemical modalities for oligonucleotide-based therapeutics.

Agenda Sessions

  • siRNA Phosphate Backbone Engineering to Enhance Potency and Extrahepatic Tissue Accumulation